Navigation Links
Protecting the body in good times and bad
Date:7/16/2013

The nasty side effects of radiation and chemotherapy are well known: fatigue, hair loss and nausea, to name a few. Cancer treatment can seem as harsh as the disease because it can't differentiate healthy cells from cancerous cells, killing both.

But what if there were a way to control or stop the growth of cancer cells without harming other cells?

Brandeis biologist Michael T. Marr is one step closer to understanding how cells promote and inhibit protein synthesis an essential part of cellular reproduction during times of stress. His new paper, co-authored by graduate students Calla Olson, Marissa Donovan and Michael Spellberg, is published in eLife, an open access digital publication for life science and biomedicine research.

Marr and his team discovered a mechanism, like an emergency backup system, that allows cells to synthesize certain proteins while shutting down the production of others. Building proteins requires a chain reaction with a dozen moving parts, each triggering the next step. These chain reactions are called signaling pathways.

The pathway that interests Marr and his team is called the insulin and insulin-like receptor (IIS) pathway. It is part of the body's emergency response system. When organisms are healthy and safe, the IIS pathway increases the activity of a protein complex called eIF4A, which helps in the synthesis of proteins.

But let's say you're not safe. You're starving. Your body is being deprived of nutrients, forcing you to conserve energy and resources. The IIS pathway, sensitive to this stress, realizes something isn't right, and sends a signal to stop eIF4A.

Protein synthesis screeches to a halt for the most part.

Marr and his team discovered that the messages that build insulin receptor proteins have internal mechanisms allowing them to synthesize protein without the eIF4A kick-start. When the rest of the production line slows down, production of insulin receptors in the IIS ramps up. Why?

The hope is you're about to find food. The insulin receptors help the IIS pathway recognize when it's out of danger. The more receptors, the faster the IIS pathway can start ramping up protein production again. The same principle applies on the cellular level when cancerous cells overwhelm healthy cells, starving them of oxygen and nutrients the healthy cells continue to produce insulin receptors.

"Even during times of stress, cells are stockpiling for good times," says Marr.

The mechanism that allows synthesis of insulin receptors during stress is the same from flies to mammals, pointing to a response conserved in evolution, Marr says.

Though this research is still early, the more deeply scientists understand mechanisms involved in growth and inhibition, the better they can decipher diseases that rely on uncontrolled cell growth, like cancer.


'/>"/>

Contact: Leah Burrows
lburrows@brandeis.edu
781-736-4027
Brandeis University
Source:Eurekalert

Related medicine news :

1. Small molecular bodyguards kill HPV-infected cancer cells by protecting tumor-suppressor
2. Protecting the hearts of those waiting for kidney and liver transplants
3. Stem-cell-protecting drug could prevent the harmful side effects of radiation therapy
4. Protecting psychiatric medical records puts patients at risk of hospitalization
5. TraceLink Life Sciences Cloud Named Amazon AWS Grand Prize Winner for Protecting Patients, Enabling Health, Ensuring Track and Trace Compliance
6. Young Athletes Urged to Use Face-Protecting Gear
7. The Truck Accident Victims’ Guide By Block O’Toole & Murphy, LLP: Protecting Yourself After A Collision With A Tractor-Trailer
8. Cosmetic Surgery – Protecting Consumers from Unlicensed Practitioners
9. Protecting Landscapes from Wildlife Damage
10. Kowalli Offers Tips for Protecting Your Baby This Summer
11. Ethical quandary about vaccinations sparked by tension between parental rights and protecting public health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... ... ... A total solar eclipse will occur across the U.S. on Monday, August 21, ... the sun and Earth. This rare event will be magnificent to witness, but what does ... on the road during the total eclipse of the sun. , 1. Plan ahead. The ...
(Date:8/20/2017)... ... , ... Are you an adult with gluten intolerance or Celiac disease living ... in participating in a research study that focuses on family interactions when dealing with ... relational aspects of adults who have gluten sensitivities who cohabitate with other adults who ...
(Date:8/19/2017)... ... 18, 2017 , ... Paragon and IOTA ... help the cannabis industry move towards greater legitimacy. By incorporating IOTA’s unique approach ... with lower fees. Paragon will build a fully verifiable database to track prescriptions, ...
(Date:8/19/2017)... ... 2017 , ... Curl Keeper® is excited to announce that the H2O Water ... Award for the second year in a row. The H2O Bottle, a refillable ultra-fine ... Best Moisturizer for Type 2 Wavies and Best Refresher for Type 2 Wavies in ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... a diverse community of over 1,000 passionate employees, caregivers, volunteers, thought leaders, researchers, ... at Stonegate changed ownership, it was time to refresh the carpeting with the ...
Breaking Medicine News(10 mins):
(Date:8/18/2017)... -- Nortis today announced the awarding of a $688K National Institutes of Health (NIH) grant. ... a Small Business Innovation Research (SBIR)?Fast-track grant under award number ... Stroke (NINDS).?  ... Nortis ParVivo Chip used for 3D Organs-on-Chip Applications ... The neurotherapeutics sector is ...
(Date:8/17/2017)... ANGELES , Aug. 17, 2017 MJAC2017 ... CBMJ – Canna Broadcast Media, today reveals its leading lineup. ... Isodiol International Inc., a global cannabis innovator specializing in the ... sponsor of the conference. MassRoots, Rambridge™ and The Green Organic ... Bay Inc. and Namaste Vapes™ as silver sponsors. ...
(Date:8/17/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... and big data solutions, announced today that it ... non-U.S. investors for the sale of shares of ... Company,s newly designated Series B Convertible Preferred Stock ... to conduct a closing with respect to the ...
Breaking Medicine Technology: